21st Century Advances in Multimodality Imaging of Obesity for Care of the Cardiovascular Patient
Open accessThe DOI matches its Crossref record; 33 of the 33 references it cites were found in a registry or an index.
Abstract
Although obesity is typically defined by body mass index criteria, this does not differentiate true body fatness, as this includes both body fat and muscle. Therefore, other fat depots may better define cardiometabolic and cardiovascular disease (CVD) risk imposed by obesity. Data from translational, epidemiologic, and clinical studies over the past three decades have clearly demonstrated that accumulation of adiposity in the abdominal viscera and within tissue depots lacking physiologic adipose tissue storage capacity (termed “ectopic fat”) are strongly associated with the development of a clinical syndrome characterized by atherogenic dyslipidemia, hyperinsulinemia/glucose intolerance/type 2 diabetes mellitus, hypertension, atherosclerosis, and abnormal cardiac remodeling and heart failure. In this State-of-the-Art review, we discuss the impact of various body fat depots on cardiometabolic parameters and CVD risk. Specifically, we review novel and emerging imaging techniques to evaluate adiposity and the risk of cardiometabolic diseases and CVD.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
2013 ACC/AHA Guideline on the Assessment of Cardiovascular Risk
Goff, D. C., Lloyd-Jones, D. M., Bennett, G., Coady, S., D’Agostino, R. B., Gibbons, R., Greenland, P., Lackland, D. T., Levy, D., O’Donnell, C. J., et al. (2014) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2013.11.005 · Cited by 4,945
2013 AHA/ACC/TOS Guideline for the Management of Overweight and Obesity in Adults
Jensen, M. D., Ryan, D. H., Apovian, C. M., Ard, J. D., Comuzzie, A. G., Donato, K. A., Hu, F. B., Hubbard, V. S., Jakicic, J. M., Kushner, R. F., et al. (2014) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2013.11.004 · Cited by 4,058
Fox, C. S., Massaro, J. M., Hoffmann, U., Pou, K. M., Maurovich-Horvat, P., Liu, C.-Y., Vasan, R. S., Murabito, J. M., Meigs, J. B., Cupples, L. A., et al. (2007) · Circulation · doi:10.1161/circulationaha.106.675355 · Cited by 2,882 · cited 4×
“Irlbeck T, Massaro JM, Bamberg F, O’Donnell CJ, Hoffmann U, Fox CS. Association between single-slice measurements of visceral and abdominal subcutaneous adipose tissue with volumetric measurements: the Framingham Heart Study.”
MethodInfluentialPathophysiology of human visceral obesity: an update
Tchernof, A., & Després, J.-P. (2013) · Physiological Reviews · doi:10.1152/physrev.00033.2011 · Cited by 2,583 · cited 1×
“Although BMI is a simple and useful screening tool in the population to identify excess body fat, its use as a diagnostic measure is limited due to its lack of specificity for obesity-related health risks (4) and remarkably heterogeneous relationship to long-term cardiovascular and metabolic consequences (5).”
BackgroundGarvey, W. T., Mechanick, J. I., Brett, E. M., Garber, A. J., Hurley, D. L., Jastreboff, A. M., Nadolsky, K., Pessah-Pollack, R., & Plodkowski, R. (2016) · Endocrine Practice · doi:10.4158/ep161365.gl · Cited by 1,914
Visceral and ectopic fat, atherosclerosis, and cardiometabolic disease: a position statement
Neeland, I. J., Ross, R., Després, J.-P., Matsuzawa, Y., Yamashita, S., Shai, I., Seidell, J., Magni, P., Santos, R. D., Arsenault, B., et al. (2019) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(19)30084-1 · Cited by 1,603 · cited 2×
“The contribution of VAT to the pathogenesis of atherosclerotic CVD, heart failure, hypertension, type 2 diabetes mellitus, and other CVD risk factors, as well as the prognostic implications of excess VAT independent of BMI has been extensively reviewed elsewhere and the reader is directed to those articles for further…”
BackgroundSelf-citationBody Fat Distribution and Risk of Cardiovascular Disease: An Update
Després, J.-P. (2012) · Circulation · doi:10.1161/circulationaha.111.067264 · Cited by 1,481
Pharmacological Management of Obesity: An Endocrine Society Clinical Practice Guideline
Apovian, C. M., Aronne, L. J., Bessesen, D. H., McDonnell, M. E., Murad, M. H., Pagotto, U., Ryan, D. H., & Still, C. D. (2015) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2014-3415 · Cited by 1,347
Ascha, M. S., Hanouneh, I. A., Lopez, R., Tamimi, T. A.-R., Feldstein, A. F., & Zein, N. N. (2010) · Hepatology · doi:10.1002/hep.23527 · Cited by 1,296
Camacho, P. M., Petak, S. M., Binkley, N., Clarke, B. L., Harris, S. T., Hurley, D. L., Kleerekoper, M., Lewiecki, E. M., Miller, P. D., Narula, H. S., et al. (2016) · Endocrine Practice · doi:10.4158/ep161435.esgl · Cited by 1,140
Neeland, I. J., Poirier, P., & Després, J.-P. (2018) · Circulation · doi:10.1161/circulationaha.117.029617 · Cited by 881
Self-citationIntramyocardial lipid accumulation in the failing human heart resembles the lipotoxic rat heart
Sharma, S., Adrogue, J. V., Golfman, L., Uray, I., Lemm, J., Youker, K., Noon, G. P., Frazier, O. H., & Taegtmeyer, H. (2004) · The FASEB Journal · doi:10.1096/fj.04-2263com · Cited by 790 · cited 1×
“Fatty infiltration of myocardial cells was first identified in patients with HF and severe metabolic dysregulation as a sign of cardiac lipotoxicity (58).”
BackgroundKim, D., Kim, R. W., Kim, H. J., & Therneau, T. M. (2013) · Hepatology · doi:10.1002/hep.26156 · Cited by 772 · cited 3×
“However, cirrhosis has a similar appearance on ultrasonography, which limits the specificity of ultrasound for differentiating between NAFLD, NASH, and cirrhotic liver disease (69).”
BackgroundEchocardiographic epicardial fat: a review of research and clinical applications
Iacobellis, G., & Willens, H. J. (2009) · Journal of the American Society of Echocardiography · doi:10.1016/j.echo.2009.10.013 · Cited by 700 · cited 1×
“Echocardiography also has advantages, including lower cost, easy accessibility and good reproducibility (49).”
BackgroundDual‐Energy X‐Ray Absorptiometry for Quantification of Visceral Fat
Kaul, S., Rothney, M. P., Peters, D. M., Wacker, W. K., Davis, C. E., Shapiro, M. D., & Ergun, D. L. (2012) · Obesity · doi:10.1038/oby.2011.393 · Cited by 622
Cardiac Steatosis in Diabetes Mellitus: A 1 H-Magnetic Resonance Spectroscopy Study
McGavock, J. M., Lingvay, I., Zib, I., Tillery, T., Salas, N., Unger, R., Levine, B. D., Raskin, P., Victor, R. G., & Szczepaniak, L. S. (2007) · Circulation · doi:10.1161/circulationaha.106.645614 · Cited by 612 · cited 14×
“However, several clinical trials have demonstrated that therapies that improve beta cell function in T2DM and prediabetes are not accompanied by concomitant improvement in pancreatic steatosis.”
BackgroundInfluentialRijzewijk, L. J., van der Meer, R. W., Smit, J. W. A., Diamant, M., Bax, J. J., Hammer, S., Romijn, J. A., de Roos, A., & Lamb, H. J. (2008) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2008.07.062 · Cited by 559 · cited 14×
“However, several clinical trials have demonstrated that therapies that improve beta cell function in T2DM and prediabetes are not accompanied by concomitant improvement in pancreatic steatosis.”
BackgroundInfluentialPiché, M.-E., Poirier, P., Lemieux, I., & Després, J.-P. (2018) · Progress in Cardiovascular Diseases · doi:10.1016/j.pcad.2018.06.004 · Cited by 558 · cited 1×
“Although beyond the scope of this article, comprehensive discussions of the contributions of obesity and body fat distribution to CVD have been recently reviewed (7,10).”
BackgroundNeeland, I. J., Ayers, C. R., Rohatgi, A. K., Turer, A. T., Berry, J. D., Das, S. R., Vega, G. L., Khera, A., McGuire, D. K., Grundy, S. M., et al. (2013) · Obesity · doi:10.1002/oby.20135 · Cited by 497
Self-citationHeymsfield, S. B., Gonzalez, M. C., Lu, J., Jia, G., & Zheng, J. (2015) · Proceedings of the Nutrition Society · doi:10.1017/s0029665115000129 · Cited by 483
Visceral Adiposity and the Risk of Metabolic Syndrome Across Body Mass Index
Shah, R. V., Murthy, V. L., Abbasi, S. A., Blankstein, R., Kwong, R. Y., Goldfine, A. B., Jerosch-Herold, M., Lima, J. A. C., Ding, J., & Allison, M. A. (2014) · JACC: Cardiovascular Imaging · doi:10.1016/j.jcmg.2014.07.017 · Cited by 427 · cited 5×
“Shah RV, Anderson A, Ding J et al. Pericardial, But Not Hepatic, Fat by CT Is Associated With CV Outcomes and Structure: The Multi-Ethnic Study of Atherosclerosis.”
MethodInfluentialDubé, J. J., Amati, F., Stefanovic-Racic, M., Toledo, F. G. S., Sauers, S. E., & Goodpaster, B. H. (2008) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00769.2007 · Cited by 378 · cited 1×
“Compared to imaging, spatial coverage of localized 1H MRS is limited to a single muscle group per measurement, but it permits separate measurements of intramyocellular lipid (IMCL) and extramyocellular lipid (EMCL) by exploiting slight differences in their nuclear resonance frequency– a distinction that may be importa…”
BackgroundDiamant, M., Lamb, H. J., Groeneveld, Y., Endert, E. L., Smit, J. W. A., Bax, J. J., Romijn, J. A., de Roos, A., & Radder, J. K. (2003) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(03)00625-9 · Cited by 372
Gepner, Y., Shelef, I., Schwarzfuchs, D., Zelicha, H., Tene, L., Yaskolka Meir, A., Tsaban, G., Cohen, N., Bril, N., Rein, M., et al. (2018) · Circulation · doi:10.1161/circulationaha.117.030501 · Cited by 279
The Relationship of Body Mass and Fat Distribution With Incident Hypertension
Chandra, A., Neeland, I. J., Berry, J. D., Ayers, C. R., Rohatgi, A., Das, S. R., Khera, A., McGuire, D. K., de Lemos, J. A., & Turer, A. T. (2014) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2014.05.057 · Cited by 264
Self-citationIacobellis, G., Leonetti, F., Singh, N., & M Sharma, A. (2007) · International Journal of Cardiology · doi:10.1016/j.ijcard.2006.04.016 · Cited by 224 · cited 1×
“compared left atrial dimensions and diastolic function in 30 patients with advanced obesity and 20 controls with normal BMI; obese patients had larger left atrial size, more impaired diastolic filling, and higher epicardial fat thickness compared with controls (47).”
BackgroundBody Composition Profiling in the UK Biobank Imaging Study
Linge, J., Borga, M., West, J., Tuthill, T., Miller, M. R., Dumitriu, A., Thomas, E. L., Romu, T., Tunón, P., Bell, J. D., et al. (2018) · Obesity · doi:10.1002/oby.22210 · Cited by 223
Guideline Recommendations for Obesity Management
Ryan, D. H., & Kahan, S. (2018) · Medical Clinics of North America · doi:10.1016/j.mcna.2017.08.006 · Cited by 221
Effects of Bariatric Surgery on Cardiac Ectopic Fat
Gaborit, B., Jacquier, A., Kober, F., Abdesselam, I., Cuisset, T., Boullu-Ciocca, S., Emungania, O., Alessi, M.-C., Clément, K., Bernard, M., et al. (2012) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2012.06.016 · Cited by 205 · cited 2×
“Furthermore, weight loss through bariatric surgery has not been shown to change intramyocardial fat content despite significant reductions in other fat depots (61).”
BackgroundIntramyocellular Lipid Content in Human Skeletal Muscle
Schrauwen‐Hinderling, V. B., Hesselink, M. K. C., Schrauwen, P., & Kooi, M. E. (2006) · Obesity · doi:10.1038/oby.2006.47 · Cited by 202
Epicardial and pericardial fat: Close, but very different
Iacobellis, G. (2009) · Obesity · doi:10.1038/oby.2008.575 · Cited by 194
Characterisation of liver fat in the UK Biobank cohort
Wilman, H. R., Kelly, M., Garratt, S., Matthews, P. M., Milanesi, M., Herlihy, A., Gyngell, M., Neubauer, S., Bell, J. D., Banerjee, R., et al. (2017) · PLOS ONE · doi:10.1371/journal.pone.0172921 · Cited by 159
Miljkovic, I., Kuipers, A. L., Cauley, J. A., Prasad, T., Lee, C. G., Ensrud, K. E., Cawthon, P. M., Hoffman, A. R., Dam, T.-T., Gordon, C. L., et al. (2015) · The Journals of Gerontology Series A: Biological Sciences and Medical Sciences · doi:10.1093/gerona/glv027 · Cited by 144
Cited by
Obesity and Cancer: A Current Overview of Epidemiology, Pathogenesis, Outcomes, and Management
Pati, S., Irfan, W., Jameel, A., Ahmed, S., & Shahid, R. K. (2023) · Cancers · doi:10.3390/cancers15020485 · Cited by 677
Neeland, I. J., Lim, S., Tchernof, A., Gastaldelli, A., Rangaswami, J., Ndumele, C. E., Powell-Wiley, T. M., & Després, J.-P. (2024) · Nature Reviews Disease Primers · doi:10.1038/s41572-024-00563-5 · Cited by 463
“…personalized medicine approach to identify clinical manifestations of MetS in their early stages include: the use of novel imaging techniques to quantify the amount and quality of VAT and ectopic adipose tissue 139,141 ; and the use of genetic risk scores for screening and prognostication of MetS.”
Self-citationObesity and the risk of cardiometabolic diseases
Valenzuela, P. L., Carrera-Bastos, P., Castillo-García, A., Lieberman, D. E., Santos-Lozano, A., & Lucia, A. (2023) · Nature Reviews Cardiology · doi:10.1038/s41569-023-00847-5 · Cited by 452
Obesity and Outcomes in COVID-19: When an Epidemic and Pandemic Collide
Sanchis-Gomar, F., Lavie, C. J., Mehra, M. R., Henry, B. M., & Lippi, G. (2020) · Mayo Clinic Proceedings · doi:10.1016/j.mayocp.2020.05.006 · Cited by 370
Self-citationMechanistic Insights of Empagliflozin in Nondiabetic Patients With HFrEF
Requena-Ibáñez, J. A., Santos-Gallego, C. G., Rodriguez-Cordero, A., Vargas-Delgado, A. P., Mancini, D., Sartori, S., Atallah-Lajam, F., Giannarelli, C., Macaluso, F., Lala, A., et al. (2021) · JACC: Heart Failure · doi:10.1016/j.jchf.2021.04.014 · Cited by 264
Metadata
- Authors
- Neeland, I. J., Yokoo, T., Leinhard, O. D., & Lavie, C. J.
- Venue
- JACC: Cardiovascular Imaging
- Publisher
- Elsevier BV
- Published
- 2021-02
- Volume
- 14
- Issue
- 2
- Pages
- 482-494
- ISSN
- 1876-7591 (ISSN-L)
- 1936-878X
- OpenAlex
- W3016777081
- Cited by
- 53
- References
- 33
- FWCI
- 3.21
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.